title: Safety, tolerability, and self-rated effects of aripiprazole and ropinirole treatment for cocaine dependence: a pilot study.
authors.forename: Milo
authors.initials: M
authors.lastname: Meini
authors.forename: Marco
authors.initials: M
authors.lastname: Moncini
authors.forename: Donatella
authors.initials: D
authors.lastname: Cecconi
authors.forename: Valerio
authors.initials: V
authors.lastname: Cellesi
authors.forename: Luca
authors.initials: L
authors.lastname: Biasci
authors.forename: Gianluca
authors.initials: G
authors.lastname: Simoni
authors.forename: Matteo
authors.initials: M
authors.lastname: Ameglio
authors.forename: Mario
authors.initials: M
authors.lastname: Pellegrini
authors.forename: Rocco N
authors.initials: RN
authors.lastname: Forgione
authors.forename: Paola
authors.initials: P
authors.lastname: Rucci
mesh_terms: D000328:Adult; D014150:Antipsychotic Agents / Q000009:adverse effects / Q000627:therapeutic use; D000068180:Aripiprazole; D019970:Cocaine-Related Disorders / Q000188:drug therapy*; D018491:Dopamine Agonists / Q000009:adverse effects / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007211:Indoles / Q000009:adverse effects* / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D010865:Pilot Projects; D010879:Piperazines / Q000009:adverse effects* / Q000627:therapeutic use*; D015363:Quinolones / Q000009:adverse effects* / Q000627:therapeutic use*; D057566:Self Report
chemical_list: D014150:Antipsychotic Agents; D018491:Dopamine Agonists; D007211:Indoles; D010879:Piperazines; D015363:Quinolones; C046649:ropinirole; D000068180:Aripiprazole